ジフテリアの世界市場レポート 2025年

細菌感染症の流行増加は、今後数年間のジフテリア市場の成長を促進すると予想されています。細菌感染症は、細菌が体内に侵入し、直接感染または毒素の産生によって病気を引き起こすことで発生します。深刻な細菌感染症であるジフテリアは、コリネバクテリウム・ジフテリア（Corynebacterium diphtheriae）の菌株によって引き起こされ、免疫システムを弱め、細菌の増殖を促進します。例えば、2024年9月、英国政府のウェブサイトであるGOV.UKによると、イングランドのNHS急性トラストでは、2022-2023会計年度中に38,757件の大腸菌菌血症が報告され、そのうち7,881件（20.3％）が病院発症の感染症でした。細菌感染症は増加の一途をたどっており、ジフテリア市場もそれに伴い成長が見込まれます。

ジフテリア市場は、予防接種プログラムの増加傾向に支えられて成長を遂げています。予防接種プログラムは、ワクチン接種によって予防可能な病気から個人を守ることを目的とした一連のサービスを包含しています。これらのプログラムは、ワクチンで予防可能な病気に起因する病気、障害、死亡を抑制することを目的としています。ジフテリアやその他のワクチンは、さまざまな国や地域にまたがる予防接種イニシアチブを通じて、個人に日常的に投与されています。例えば、2023年7月、国連国際児童緊急基金（UNICEF）は、ジフテリア、破傷風、百日咳（DTP3）の3回目の接種率が世界的に上昇したと報告しました。この接種率は、予防接種の努力により、2021年の81％から2022年には84％に上昇しました。その結果、予防接種プログラムの隆盛がジフテリア市場の成長を支えています。

ジフテリア市場に従事する企業は、市場ポジションを維持するため、積極的に技術革新を行い、FDAの承認を得ています。2022年10月、英国の製薬・バイオテクノロジー企業であるグラクソ・スミスクラインPLCが、米国食品医薬品局（FDA）からBOOSTRIX（破傷風トキソイド、還元型ジフテリアトキソイド、百日咳ワクチン、吸着型；Tdap）の承認を取得したと発表したのは、そうした技術革新の代表例です。この承認は、生後2ヵ月未満の乳児の百日咳を予防するため、妊娠第3期における予防接種を許可するものです。妊婦にTdapワクチンを接種することで、母から子への防御抗体の移行により、生後数ヶ月の新生児に百日咳に対する最適な防御が与えられます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ジフテリア PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のジフテリア市場：成長率分析
• 世界のジフテリア市場の実績：規模と成長, 2019-2024
• 世界のジフテリア市場の予測：規模と成長, 2024-2029, 2034F
• 世界ジフテリア総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のジフテリア市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ジフテリア
• スキンジフテリア
• その他のタイプ
• 世界のジフテリア市場診断による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 身体検査
• 咽頭培養
• その他の診断
• 世界のジフテリア市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗生物質
• 抗毒素
• その他の治療法
• 世界のジフテリア市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界のジフテリア市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 専門クリニック
• その他のエンドユーザー
• 世界のジフテリア市場ジフテリアの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 呼吸器系ジフテリア
• 非呼吸器系ジフテリア
• 世界のジフテリア市場、皮膚ジフテリアの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 皮膚のジフテリア
• 世界のジフテリア市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心筋炎
• ジフテリア性神経炎

第7章 地域別・国別分析

• 世界のジフテリア市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のジフテリア市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ジフテリア市場：競合情勢
• ジフテリア市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Co Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• Sanofi SA
• Bristol-Myers Squibb Co.
• AstraZeneca plc
• GlaxoSmithKline plc
• Eli Lilly and Company
• Gilead Sciences Inc.
• Amgen Inc.
• Moderna Inc.
• BioNTech SE
• Regeneron Pharmaceuticals Inc.
• Biogen Inc.
• Vertex Pharmaceuticals Inc.
• Serum Institute of India
• Novavax Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ジフテリア市場2029：新たな機会を提供する国
• ジフテリア市場2029：新たな機会を提供するセグメント
• ジフテリア市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Diphtheria is a bacterial disease caused by strains of bacteria known as Corynebacterium diphtheriae. These bacteria produce a toxin that primarily affects the mucous membranes of the throat and nose and can also impact other parts of the body, particularly in severe cases. Diphtheria is characterized by symptoms such as throat discomfort, weakness, fever, swollen neck glands, breathing difficulties due to the blockage of tissues in the nose and throat, and swallowing difficulties.

The main types of infections related to diphtheria encompass diphtheria, skin diphtheria, and others. Diphtheria is a dangerous bacterial infection that can affect the tonsils, nose, throat, and/or skin and is caused by toxin-producing Corynebacterium diphtheriae bacteria. Diagnosis typically involves a physical examination and throat culture and can be confirmed with the use of antibiotics, antitoxins, and other treatment approaches. Diphtheria-related products and treatments are distributed through various channels, including hospital pharmacies, online pharmacies, and retail pharmacies. These products and therapies are employed in a range of healthcare settings, including hospitals, homecare, specialty clinics, and others.

The diphtheria market research report is one of a series of new reports from The Business Research Company that provides diphtheria market statistics, including diphtheria industry global market size, regional shares, competitors with a diphtheria market share, detailed diphtheria market segments, market trends and opportunities and any further data you may need to thrive in the diphtheria industry. This diphtheria market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diphtheria market size has grown strongly in recent years. It will grow from $8.91 billion in 2024 to $9.51 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to vaccine development, immunization campaigns, increased awareness, healthcare infrastructure.

The diphtheria market size is expected to see strong growth in the next few years. It will grow to $12.35 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to emerging outbreaks, booster vaccination programs, global travel and migration, public health preparedness. Major trends in the forecast period include combination vaccines, telemedicine for vaccination, vaccine equity initiatives, public-private partnerships.

The rising prevalence of bacterial infections is expected to drive the growth of the diphtheria market in the coming years. Bacterial infections occur when bacteria invade the body, causing illness either through direct infection or by producing toxins. Diphtheria, a serious bacterial infection, is caused by strains of Corynebacterium diphtheriae, which weaken the immune system and promote bacterial growth. For example, in September 2024, according to GOV.UK, a UK government website, NHS acute trusts in England reported 38,757 cases of E. coli bacteremia during the fiscal year 2022-2023, with 7,881 (20.3%) of these cases being hospital-onset infections. As bacterial infections continue to rise, the diphtheria market is expected to grow accordingly.

The diphtheria market is experiencing growth, largely underpinned by the upward trajectory of immunization programs. Immunization programs encompass a suite of services aimed at safeguarding individuals against vaccine-preventable illnesses by delivering vaccinations. These programs are designed to curtail sickness, disability, and mortality stemming from vaccine-preventable maladies. Diphtheria and other vaccines are routinely administered to individuals through immunization initiatives spanning different countries and regions. For instance, in July 2023, the United Nations International Children's Emergency Fund (UNICEF) reported an uptick in global coverage for the third dose of the Diphtheria, Tetanus, Pertussis (DTP3) vaccination. This coverage increased from 81% in 2021 to 84% in 2022 through immunization efforts. Consequently, the escalating prominence of immunization programs is a propellant behind the growth of the diphtheria market.

Companies engaged in the diphtheria market are actively innovating and securing FDA approvals to maintain their market positions. A prime example of such innovation occurred in October 2022 when GlaxoSmithKline PLC, a U.K.-based pharmaceutical and biotechnology firm, announced that the U.S. Food and Drug Administration (FDA) granted approval for BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, adsorbed; Tdap). This approval permits immunization during the third trimester of pregnancy to prevent pertussis (whooping cough) in infants under two months old. Administering the Tdap vaccine to pregnant women confers optimal protection against whooping cough for newborns during their initial months of life through the transference of protective antibodies from mother to child.

In December 2022, Pharmaniaga LifeScience Sdn Bhd (PLS), a pharmaceutical company headquartered in Malaysia, initiated a collaborative research agreement with BioNet-Asia Co. Ltd. (BioNet) for an undisclosed sum. This partnership focuses on the research and development of a 6-in-1 Hexavalent Vaccine targeting diseases like diphtheria (DT), tetanus (TT), pertussis (aP), poliomyelitis (IPV), Haemophilus influenzae type b (Hib), and hepatitis B (Hep-B). The collaboration is in line with Pharmaniaga's objective to establish the world's first Halal vaccine and insulin manufacturing facilities. This initiative aims to reduce Malaysia's reliance on imported life-saving vaccines and insulin, fostering the nation's goal of vaccine self-sufficiency. BioNet-Asia Co. Ltd. is a Thailand-based company specializing in the development and manufacturing of life-saving vaccines against bacterial infections, including diphtheria and tetanus.

Major companies operating in the diphtheria market are Pfizer Inc., Johnson & Johnson Co, Roche Holding AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Serum Institute of India, Novavax Inc., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Bharat Biotech International Limited, CureVac AG, Inovio Pharmaceuticals Inc., The Native Antigen Company.

Asia-Pacific was the largest region in the diphtheria market in 2024. The regions covered in diphtheria report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diphtheria market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diphtheria market consists of revenues earned by entities by providing services such as consultation, diagnosis and treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. The diphtheria market also includes the sales of medications such as vaccines, antibiotics and antitoxins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diphtheria Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diphtheria market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diphtheria ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diphtheria market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Diphtheria; Skin Diphtheria; Other Types
• 2) By Diagnosis: Physical Examination; Throat Culture; Other Diagnosis
• 3) By Treatment: Antibiotics; Antitoxin; Other Treatments
• 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 5) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Diphtheria: Respiratory Diphtheria; Non-respiratory Diphtheria
• 2) By Skin Diphtheria: Cutaneous Diphtheria
• 3) By Other Types: Diphtheritic Myocarditis; Diphtheritic Neuritis
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Co; Roche Holding AG; Merck & Co Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diphtheria Market Characteristics

3. Diphtheria Market Trends And Strategies

4. Diphtheria Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Diphtheria Growth Analysis And Strategic Analysis Framework

• 5.1. Global Diphtheria PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Diphtheria Market Growth Rate Analysis
• 5.4. Global Diphtheria Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Diphtheria Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Diphtheria Total Addressable Market (TAM)

6. Diphtheria Market Segmentation

• 6.1. Global Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diphtheria
• Skin Diphtheria
• Other Types
• 6.2. Global Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Examination
• Throat Culture
• Other Diagnosis
• 6.3. Global Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Antitoxin
• Other Treatments
• 6.4. Global Diphtheria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.5. Global Diphtheria Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End-Users
• 6.6. Global Diphtheria Market, Sub-Segmentation Of Diphtheria, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Respiratory Diphtheria
• Non-respiratory Diphtheria
• 6.7. Global Diphtheria Market, Sub-Segmentation Of Skin Diphtheria, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cutaneous Diphtheria
• 6.8. Global Diphtheria Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Myocarditis
• Diphtheritic Neuritis

7. Diphtheria Market Regional And Country Analysis

• 7.1. Global Diphtheria Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Diphtheria Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diphtheria Market

• 8.1. Asia-Pacific Diphtheria Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diphtheria Market

• 9.1. China Diphtheria Market Overview
• 9.2. China Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diphtheria Market

• 10.1. India Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diphtheria Market

• 11.1. Japan Diphtheria Market Overview
• 11.2. Japan Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diphtheria Market

• 12.1. Australia Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diphtheria Market

• 13.1. Indonesia Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diphtheria Market

• 14.1. South Korea Diphtheria Market Overview
• 14.2. South Korea Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diphtheria Market

• 15.1. Western Europe Diphtheria Market Overview
• 15.2. Western Europe Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diphtheria Market

• 16.1. UK Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diphtheria Market

• 17.1. Germany Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diphtheria Market

• 18.1. France Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diphtheria Market

• 19.1. Italy Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diphtheria Market

• 20.1. Spain Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diphtheria Market

• 21.1. Eastern Europe Diphtheria Market Overview
• 21.2. Eastern Europe Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diphtheria Market

• 22.1. Russia Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diphtheria Market

• 23.1. North America Diphtheria Market Overview
• 23.2. North America Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diphtheria Market

• 24.1. USA Diphtheria Market Overview
• 24.2. USA Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diphtheria Market

• 25.1. Canada Diphtheria Market Overview
• 25.2. Canada Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diphtheria Market

• 26.1. South America Diphtheria Market Overview
• 26.2. South America Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diphtheria Market

• 27.1. Brazil Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diphtheria Market

• 28.1. Middle East Diphtheria Market Overview
• 28.2. Middle East Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diphtheria Market

• 29.1. Africa Diphtheria Market Overview
• 29.2. Africa Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diphtheria Market Competitive Landscape And Company Profiles

• 30.1. Diphtheria Market Competitive Landscape
• 30.2. Diphtheria Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Co Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Diphtheria Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Sanofi SA
• 31.3. Bristol-Myers Squibb Co.
• 31.4. AstraZeneca plc
• 31.5. GlaxoSmithKline plc
• 31.6. Eli Lilly and Company
• 31.7. Gilead Sciences Inc.
• 31.8. Amgen Inc.
• 31.9. Moderna Inc.
• 31.10. BioNTech SE
• 31.11. Regeneron Pharmaceuticals Inc.
• 31.12. Biogen Inc.
• 31.13. Vertex Pharmaceuticals Inc.
• 31.14. Serum Institute of India
• 31.15. Novavax Inc.

32. Global Diphtheria Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diphtheria Market

34. Recent Developments In The Diphtheria Market

35. Diphtheria Market High Potential Countries, Segments and Strategies

• 35.1 Diphtheria Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Diphtheria Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Diphtheria Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer